Invest in Your Bones Campaign
In 2002, IOF inaugurated the first phase of the Invest in Your Bones Campaign. The Campaign, now in its third phase (beginning in 2006), supports projects aimed at improving access to, and reimbursement of, diagnosis and proven therapies in individuals at high-risk of fragility fracture. The campaign is supported by a consortium of seven corporate sponsors - the Alliance for Better Bone Health (Aventis, and Procter and Gamble); Eli Lilly; MSD; Novartis; Roche/GlaxoSmithKline; Servier; and Wyeth - and has a geographic focus on France, Germany, Italy, Spain and the UK. The campaign also helps the IOF to support the "Call for Action" at the EU, through various policy and lobbying activities, including support to the European Parliament Osteoporosis Interest Group and EU Osteoporosis Consultation Panel. Other key ongoing projects supported by the campaign include the Osteoporosis Education Programme to Improve the Recognition and Reporting of Vertebral Fractures by Radiologists; an initiative involving orthopaedic surgeons aimed at optimising the care of fragility fracture patients; the development of health economics studies in osteoporosis; and support to the development of new guidelines for assessing fracture risk in individuals.